Compare NTRB & GLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTRB | GLV |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Industrial Specialties | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.1M | 77.9M |
| IPO Year | N/A | 2004 |
| Metric | NTRB | GLV |
|---|---|---|
| Price | $4.02 | $6.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.3K | ★ 38.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.17 | N/A |
| Revenue Next Year | $3,394.36 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.96 | $4.88 |
| 52 Week High | $11.68 | $6.42 |
| Indicator | NTRB | GLV |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 37.52 |
| Support Level | N/A | $6.00 |
| Resistance Level | $4.50 | $6.32 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 10.10 | 36.25 |
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.